Literature DB >> 26679098

Febuxostat-induced acute liver injury.

Matt Bohm1, Raj Vuppalanchi1, Naga Chalasani1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26679098      PMCID: PMC4764455          DOI: 10.1002/hep.28403

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  4 in total

1.  Febuxostat compared with allopurinol in patients with hyperuricemia and gout.

Authors:  Michael A Becker; H Ralph Schumacher; Robert L Wortmann; Patricia A MacDonald; Denise Eustace; William A Palo; Janet Streit; Nancy Joseph-Ridge
Journal:  N Engl J Med       Date:  2005-12-08       Impact factor: 91.245

Review 2.  Febuxostat: a selective xanthine oxidase inhibitor for the treatment of hyperuricemia and gout.

Authors:  Susan P Bruce
Journal:  Ann Pharmacother       Date:  2006-11-28       Impact factor: 3.154

3.  Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout.

Authors:  Michael A Becker; H Ralph Schumacher; Patricia A MacDonald; Eric Lloyd; Christopher Lademacher
Journal:  J Rheumatol       Date:  2009-03-13       Impact factor: 4.666

4.  Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct.

Authors:  Robert J Fontana; Paul B Watkins; Herbert L Bonkovsky; Naga Chalasani; Timothy Davern; Jose Serrano; James Rochon
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

  4 in total
  9 in total

1.  ISMP Adverse Drug Reactions: Sildenafil-Induced Erythema Multiforme Acute Liver Injury Due to Febuxostat Intravenous Acetaminophen-Induced Acute Hepatotoxicity Acute Transient Myopia Induced by Zanamivir Lidocaine-Induced Hoigne Syndrome.

Authors:  Michael A Mancano
Journal:  Hosp Pharm       Date:  2016-12

2.  Polyvinylpyrrolidone-Modified Taxifolin Liposomes Promote Liver Repair by Modulating Autophagy to Inhibit Activation of the TLR4/NF-κB Signaling Pathway.

Authors:  Qiteng Ding; Wencong Liu; Xinglong Liu; Chuanbo Ding; Yingchun Zhao; Ling Dong; Huiying Chen; Shuwen Sun; Yiwen Zhang; Jinping Zhang; Ming Wu
Journal:  Front Bioeng Biotechnol       Date:  2022-06-01

Review 3.  Recent Advances in the Histopathology of Drug-Induced Liver Injury.

Authors:  David E Kleiner
Journal:  Surg Pathol Clin       Date:  2018-06

4.  Isoorientin exerts a urate-lowering effect through inhibition of xanthine oxidase and regulation of the TLR4-NLRP3 inflammasome signaling pathway.

Authors:  Meng-Fei An; Ming-Yue Wang; Chang Shen; Ze-Rui Sun; Yun-Li Zhao; Xuan-Jun Wang; Jun Sheng
Journal:  J Nat Med       Date:  2020-11-13       Impact factor: 2.343

Review 5.  Side Effects and Interactions of the Xanthine Oxidase Inhibitor Febuxostat.

Authors:  Andreas Jordan; Ursula Gresser
Journal:  Pharmaceuticals (Basel)       Date:  2018-05-25

Review 6.  From purines to purinergic signalling: molecular functions and human diseases.

Authors:  Zhao Huang; Na Xie; Peter Illes; Francesco Di Virgilio; Henning Ulrich; Alexey Semyanov; Alexei Verkhratsky; Beata Sperlagh; Shu-Guang Yu; Canhua Huang; Yong Tang
Journal:  Signal Transduct Target Ther       Date:  2021-04-28

Review 7.  Hyperuricemia-Related Diseases and Xanthine Oxidoreductase (XOR) Inhibitors: An Overview.

Authors:  Changyi Chen; Jian-Ming Lü; Qizhi Yao
Journal:  Med Sci Monit       Date:  2016-07-17

8.  Concomitant febuxostat enhances methotrexate-induced hepatotoxicity by inhibiting breast cancer resistance protein.

Authors:  Kenji Ikemura; Shun-Ichi Hiramatsu; Yuri Shinogi; Yusuke Nakatani; Isao Tawara; Takuya Iwamoto; Naoyuki Katayama; Masahiro Okuda
Journal:  Sci Rep       Date:  2019-12-30       Impact factor: 4.379

9.  N-Butyrylated hyaluronic acid ameliorates gout and hyperuricemia in animal models.

Authors:  Lanzhou Li; Di Wang; Xueju Wang; Ruifeng Bai; Chunyu Wang; Yin Gao; Tassos Anastassiades
Journal:  Pharm Biol       Date:  2019-12       Impact factor: 3.503

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.